| UniProt ID | AR6P6_HUMAN | |
|---|---|---|
| UniProt AC | Q8N6S5 | |
| Protein Name | ADP-ribosylation factor-like protein 6-interacting protein 6 | |
| Gene Name | ARL6IP6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 226 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MSFAESGWRSALRRRGPGTPGPVARPSYSSFTQGDSWGEGEVDEEEGCDQVARDLRAEFSAGAWSEPRKRSVLPPDGNGSPVLPDKRNGIFPAAAGSRAQPRRWPVQVLSILCSLLFAILLAFLLAIAYLIVKELHAENLKNEDDVDTGLLGFWTLLIISLTAGFSCCSFSWTVTYFDSFEPGMFPPTPLSPARFKKLTGHSFHMGYSMAILNGIVAALTVAWCLM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSFAESGWR ------CCHHHHHHH | 32.91 | 23401153 | |
| 6 | Phosphorylation | --MSFAESGWRSALR --CCHHHHHHHHHHH | 39.98 | 22199227 | |
| 10 | Phosphorylation | FAESGWRSALRRRGP HHHHHHHHHHHHHCC | 25.75 | 22199227 | |
| 19 | Phosphorylation | LRRRGPGTPGPVARP HHHHCCCCCCCCCCC | 28.36 | 23401153 | |
| 27 | Phosphorylation | PGPVARPSYSSFTQG CCCCCCCCCCCCCCC | 31.90 | 28450419 | |
| 28 | Phosphorylation | GPVARPSYSSFTQGD CCCCCCCCCCCCCCC | 15.83 | 28450419 | |
| 29 | Phosphorylation | PVARPSYSSFTQGDS CCCCCCCCCCCCCCC | 24.26 | 28450419 | |
| 30 | Phosphorylation | VARPSYSSFTQGDSW CCCCCCCCCCCCCCC | 24.87 | 28450419 | |
| 32 | Phosphorylation | RPSYSSFTQGDSWGE CCCCCCCCCCCCCCC | 33.32 | 28450419 | |
| 36 | Phosphorylation | SSFTQGDSWGEGEVD CCCCCCCCCCCCCCC | 43.75 | 23927012 | |
| 48 | S-palmitoylation | EVDEEEGCDQVARDL CCCCCCCHHHHHHHH | 3.60 | 29575903 | |
| 60 | Phosphorylation | RDLRAEFSAGAWSEP HHHHHHHHCCCCCCC | 19.80 | 30266825 | |
| 65 | Phosphorylation | EFSAGAWSEPRKRSV HHHCCCCCCCCCCCC | 36.87 | 30266825 | |
| 71 | Phosphorylation | WSEPRKRSVLPPDGN CCCCCCCCCCCCCCC | 30.92 | 30266825 | |
| 80 | Phosphorylation | LPPDGNGSPVLPDKR CCCCCCCCCCCCCCC | 18.81 | 23401153 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AR6P6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AR6P6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AR6P6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| YKT6_HUMAN | YKT6 | physical | 26186194 | |
| DUS3_HUMAN | DUSP3 | physical | 26186194 | |
| PNPO_HUMAN | PNPO | physical | 26186194 | |
| BLVRB_HUMAN | BLVRB | physical | 26186194 | |
| GSTM1_HUMAN | GSTM1 | physical | 26186194 | |
| PEBB_HUMAN | CBFB | physical | 26186194 | |
| PMVK_HUMAN | PMVK | physical | 26186194 | |
| NAA50_HUMAN | NAA50 | physical | 26186194 | |
| UB2D2_HUMAN | UBE2D2 | physical | 26186194 | |
| PYGB_HUMAN | PYGB | physical | 26186194 | |
| SNX3_HUMAN | SNX3 | physical | 26186194 | |
| PNPO_HUMAN | PNPO | physical | 28514442 | |
| DUS3_HUMAN | DUSP3 | physical | 28514442 | |
| PMVK_HUMAN | PMVK | physical | 28514442 | |
| SNX3_HUMAN | SNX3 | physical | 28514442 | |
| GSTM1_HUMAN | GSTM1 | physical | 28514442 | |
| NAA50_HUMAN | NAA50 | physical | 28514442 | |
| CHM4A_HUMAN | CHMP4A | physical | 28514442 | |
| PEBB_HUMAN | CBFB | physical | 28514442 | |
| YKT6_HUMAN | YKT6 | physical | 28514442 | |
| BLVRB_HUMAN | BLVRB | physical | 28514442 | |
| BID_HUMAN | BID | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-65, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-36; SER-65 ANDSER-80, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19, AND MASSSPECTROMETRY. | |